Antibodies and myositis Archives - ACR Meeting Abstracts

Abstract Number: 299 • ACR/ARHP Annual Meeting 2015
Subcutaneous Edema, Distal Weakness and Dysphagia Associated with the NXP2 Antibody
Jemima Albayda¹, Iago Pinal-Fernandez², Lisa Christopher-Stine³, Sonye K. Danoff⁴, Cheilonda Johnson⁵, Christopher Mecoli⁶, Julie J. Paik⁷, Alim Ramji⁸ and Andrew Mammen⁹, ¹Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ²Autoimmune Systemic Diseases Unit, Vall D’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain, ³Ste 4100 Rm 409, Johns Hopkins University School of Medicine, Baltimore, MD, ⁴Medicine/Pulmonary, Johns Hopkins School of Medicine, Baltimore, MD, ⁵Medicine/Pulmonology, Johns Hopkins University, Baltimore, MD, ⁶Rheumatology, Johns Hopkins University, Baltimore, MD, ⁷Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ⁸School of Medicine, Johns Hopkins University, Baltimore, MD, ⁹Center Tower Ste 5300, Johns Hopkins University School of Medicine, Baltimore, MD
Background/Purpose: Myositis specific antibodies are known to be associated with specific phenotypes. The unusual presentation of subcutaneous edema, distal weakness and dysphagia was seen in…
Abstract Number: 1945 • ACR/ARHP Annual Meeting 2012
Anti-Transcription Intermediary Factor 1-Gamma (TIF1-Υ) Autoantibody Detection by ELISA and Immunoprecipitation in a Prospective Myositis Cohort: Predictive Value for Cancer Associated Myositis
Rohit Aggarwal¹, Noreen Fertig², Danielle Goudeau³, Chad Stephans⁴, Qi Zengbiao⁵, Diane Koontz⁵, Mary Lucas⁶, Marc C. Levesque³ and Chester V. Oddis⁷, ¹Rheumtology, University of Pittsburgh, Pittsburgh, PA, ²University of Pittsburgh, Pittsburgh, PA, ³Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, ⁴Rheumatology, University of Pittsburgh, Pittsburgh, PA, ⁵Department of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, ⁶Division of Rheumatology, University of Pittsburgh, Pittsburgh, PA, ⁷Rheum/Clinical Immunology, University of Pittsburgh, Pittsburgh, PA
Background/Purpose: Myositis [particularly dermatomyositis (DM)] is associated with cancer and anti-transcription intermediary factor-1 gamma (TIF1γ) is a serologic risk factor for cancer associated myositis (CAM).…

Abstracts tagged "Antibodies and myositis"

Subcutaneous Edema, Distal Weakness and Dysphagia Associated with the NXP2 Antibody

Anti-Transcription Intermediary Factor 1-Gamma (TIF1-Υ) Autoantibody Detection by ELISA and Immunoprecipitation in a Prospective Myositis Cohort: Predictive Value for Cancer Associated Myositis